Intensive Cognitive Behavioural Treatment Has Slight Edge as OCD Treatment: Presented at ADAA
While both intensive and weekly cognitive-behavioural treatment (CBT) eventually provide similar extent of improvement for obsessive-compulsive disorder (OCD), intensive treatment may be "somewhat more expedient," researchers reported here at the 27th Annual Meeting of the Anxiety Disorders Association of America (ADAA). Eric A. Storch, PhD, assistant professor, departments of psychiatry and paediatrics, University of Florida, Gainesville, Florida, United States, and associates randomised 40 children and adolescents with OCD to weekly or intensive CBT. "Cognitive-behavioural treatment with exposure and response prevention alone or with concurrent pharmacotherapy is the first-line therapy for OCD," Dr. Storch said in his presentation on March 31st. "However, a primary limitation remains access to practitioners since most research on CBT has been done in specialised academic centres rather than in routine clinical settings. Thus, patient access to treatment is limited by the availability of trained therapists, and most patients receive no treatment, medication alone, and/or non-CBT psychotherapy." A potential solution, he added, is intensive CBT.
Teens With Severe OCD Can Be Successfully Treated as Inpatients: Presented at ADAA
Investigators reported early favourable results using an intensive inpatient programme to treat adolescents with obsessive-compulsive disorder (OCD) who failed conventional outpatient treatment. "Our data show that inpatient treatment for OCD in an adolescent population is very effective in reducing symptom severity," said senior investigator Throstur Bjorgvinsson, PhD, program director, Obsessive-Compulsive Disorder Treatment Program, Menninger Clinic, Houston, Texas, United States, said at the 27th Annual Meeting of the Anxiety Disorders Association of America (ADAA). "In addition, we found a reduction in the strength of belief in constructs hypothesised to be important in the maintenance of this disorder," he said during a presentation on March 31st.